TIME logo
Sign In
My Account
My Account
Digital Magazines
TIME Storefront
Help Center
Sign Out
Subscribe
Subscribe
Sign Up for Our Entertainment Newsletter
Close
My Account
My Account
Digital Magazines
TIME Storefront
Help Center
Sign Out
Sign In
Subscribe
Sections
Home
U.S.
Politics
World
Health
Climate
Future of Work by Charter
Business
Tech
Entertainment
Ideas
Science
History
Sports
Magazine
TIME 2030
Next Generation Leaders
TIME100 Leadership Series
TIME Studios
Video
TIME100 Talks
TIMEPieces
The TIME Vault
TIME for Health
TIME for Kids
TIME Edge
TIME CO2
Red Border: Branded Content by TIME
Coupons
Personal Finance by TIME Stamped
Shopping by TIME Stamped
Join Us
Newsletters
Subscribe
Give a Gift
Shop the TIME Store
TIME Cover Store
Customer Care
US & Canada
Global Help Center
Reach Out
Careers
Press Room
Contact the Editors
Media Kit
Reprints and Permissions
More
About Us
Privacy Policy
Your Privacy Rights
Terms of Use
Modern Slavery Statement
Site Map
Connect with Us
Magazine
Jimmy Carter
By Jeffrey Kluger
Greg Adams
By Alice Park
Jeremy Farrar
By Jamie Ducharme
Dan Doctoroff
By Angela Haupt
More in
Magazine
Trent Green
During the decade Trent Green spent as an executive at Legacy Health, he saw firsthand how often primary care was undervalued. “We thought of it as a feeder to other services” rather than important in...
By Jamie Ducharme
May 2, 2024
Mandy Cohen
The U.S.’s COVID-19 public-health emergency officially ended on May 11, 2023. Almost exactly a month later, President Joe Biden announced that internal-medicine physician Dr. Mandy Cohen would take over as director of the U.S. Centers...
By Jamie Ducharme
May 2, 2024
David Ricks
It’s hard for a major pharmaceutical company to launch one successful novel drug on the market, but Dave Ricks, CEO of Eli Lilly, could potentially be overseeing two—in obesity and Alzheimer’s, both areas where there...
By Alice Park
May 2, 2024
Lars Fruergaard Jorgensen
It wasn’t always clear that semaglutide, a diabetes medication, would be equally powerful as a treatment for obesity. “Most medicines in obesity had failed, and some of them were even turning out to be dangerous...
By Alice Park
May 2, 2024
Emmanuel Macron
The French President sealed the guaranteed right to abortion into the country’s constitution on International Women’s Day 2024, declaring it a reminder of “the fate of generations of women deprived of the most intimate of...
By Kelly Mickle
May 2, 2024
Brenda Waning
Tuberculosis may not be a priority for most of the developed world right now, but that could change. “We’re seeing dramatic increases in transient populations, and TB is going to be something that people in...
By Alice Park
May 2, 2024
Michael Regan
In March 2024, the U.S. Environmental Protection Agency (EPA) announced a ban on chrysotile asbestos. It’s the last type of asbestos still legal in the U.S. (typically found in car parts and some chlorine bleach)...
By Kelly Mickle
May 2, 2024
Albert Bourla
When Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. But COVID-19 delayed those plans when Bourla decided to shift resources...
By Alice Park
May 2, 2024
Mike DeWine
Ohio Governor Mike DeWine bank-shot his way into an unlikely and unsought role as the Republican Party’s most credible leader on public health—a term he fastidiously avoids using, as the Washington Post has reported. From...
By Philip Elliott
May 2, 2024
Sumbul Desai
Dr. Sumbul Desai, vice president of health at Apple, is hoping to prove that personal-tech devices can be good for our mental health. Desai has been a key force behind new health tools on the...
By Kelly Mickle
May 2, 2024
Zahid Maleque
As a vocal backer of Bangladesh’s autocratic Prime Minister Sheikh Hasina, Zahid Maleque’s five years as Minister of Health and Family Welfare weren’t without controversy. He fended off graft allegations and faced fierce criticism for...
By Charlie Campbell
May 2, 2024
Peter Marks
In 2023, the U.S. Food and Drug Administration (FDA) brought a number of never-before-seen treatments to market, approving the first gene therapies using the gene-editing tool CRISPR. The agency approved a therapy for sickle cell...
By Alice Park
May 2, 2024
Pam Cheng
The pharmaceutical industry isn’t exactly a model of sustainability. It’s been a challenge to introduce environmentally responsible practices in an industry built on the use of fossil fuels to drive its energy needs, from expensive...
By Alice Park
May 2, 2024
Vivek Murthy
Last May, U.S. Surgeon General Dr. Vivek Murthy issued an advisory about the profound consequences of loneliness and isolation—a departure from the type of standard medical conditions many of his predecessors prioritized. He realized he...
By Angela Haupt
May 2, 2024
Khaled Kabil
A decade ago, Egypt had one of the world’s highest rates of hepatitis C, a viral infection that is spread through contact with infected blood and damages the liver, sometimes fatally. But in 2023, the...
By Jamie Ducharme
May 2, 2024
Dale Whelehan
Behavioral scientist Dale Whelehan wants you to work less—and he may even be able to convince your boss it’s a good idea. As CEO of 4 Day Week Global, the leading organization pushing for shorter...
By Jamie Ducharme
May 2, 2024
More from
TIME
More From TIME